Audited Financial Result for Half-Year and Year Ended 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Patel Chem Specialities Ltd reported strong audited results for FY2026 ended March 31, 2026. Revenue from operations grew 30.6% year-on-year to ₹13,726.33 lakhs from ₹10,508.78 lakhs. Profit after tax (PAT) increased 18.8% to ₹1,255.22 lakhs from ₹1,056.52 lakhs. EBITDA for the year stood at ₹1,889.25 lakhs with margin compression at approximately 13.8% compared to ~15% in FY2025, likely due to rising raw material costs. The company raised ₹5,880 lakhs via IPO in July 2025 and deployed ₹16.27 crores by Q3, with ₹36.24 crores remaining unutilized. Statutory auditors issued an unmodified (clean) opinion with no qualifications or emphasis of matter. Related party transactions were disclosed, including unsecured loans to Managing Director Bhupesh Patel (₹90.08 lakhs) and Whole-Time Director Anshu Patel (₹60.50 lakhs).
The clean audit opinion and strong 30%+ revenue growth are positive signals for shareholders, though the PAT growth of 18.8% and EBITDA margin compression may temper enthusiasm. The substantial IPO proceeds deployment and healthy balance sheet with cash reserves of ₹36.59 crores position the company for growth, but investors should monitor raw material cost trends.